No TAA | After TAA treatment | Statistical significance (p)* | ||||||
---|---|---|---|---|---|---|---|---|
0 hr | 1 hrs | 3 hrs | 5 hrs | 24 hrs | 48 hrs | 72 hrs | ||
SP | 1.000 | 0.527± 0.154 | 0.881 ±0.326 | 0.652 ±0.246 | 0.412±0.166 | 0.527 ±0.189 | 0.696 ±0.235 | 0.0078 |
CGRP | 1.000 | 1.119± 0.336 | 1.197 ±0.308 | 0.958 ±0.312 | 0.359 ±0.153 | 0.268 ±0.161 | 0.330 ±0.164 | < 0.0001 |
IL-1α | 1.000 | 1.183 ±0.35 | 0.342 ±0.168 | 0.185± 0.091 | 0.210 ±0.166 | 0.107± 0.114 | 0.053 ±0.027 | < 0.0001 |
TGF-β | 1.000 | 1.108 ±0.225 | 1.132 ±0.219 | 1.186±0.249 | 1.015±0.198 | 0.859 ±0.234 | 0.772 ±0.228 | 0.0187 |
Tenocyte viability | 0.582 | 0.491± 0.038 | 0.502 ±0.041 | 0.467 ±0.049 | 0.405 ±0.042 | 0.353 ±0.033 | 0.306 ±0.021 | < 0.0001 |